Product Code: QYX FDA class 2 21 CFR 870.1025

Outpatient Cardiac Telemetry

Cardiovascular

The outpatient cardiac telemetry device (product code QYX) is a Class 2 Cardiovascular prescription device (regulation 870.1025) intended to continuously record and analyze electrocardiograms in outpatient settings, with detected events transmitted to the prescribing clinician via a 24/7 attended analysis center. Requiring 510(k) clearance, it is explicitly not intended for detection or notification of hemodynamically unstable or life-threatening arrhythmias, not for patients at elevated risk of serious cardiovascular events requiring prompt intervention, and not for monitoring during cardiac rehabilitation outside healthcare facilities. It is not an implant and is not life-sustaining.

510(k)s
21
FEI Numbers
10
Registration Numbers
10
Unique Applicants
12
Years Active
27

Research product code QYX in seconds

The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.

Free to try · every answer cites its records

Basic Information

Product Code
QYX
Device Class
FDA class 2
Regulation Number
870.1025
Medical Specialty
Cardiovascular
Review Panel
CV
Submission Type
1

Device Characteristics

GMP Exempt
Implant
Life Sustain/Support
Third Party
Summary Malfunction Reporting

Definition

Devices are intended to continuously record and analyze electrocardiograms for automatic detection and recording of cardiac electrical activity in an outpatient setting. Detected, notifiable events are transmitted to the prescribing clinician during the monitoring period by a 24/7 attended analysis center after review by a qualified individual. Devices may allow remote access and display of electrocardiograms acquired. Not for use for detection or notification of hemodynamically unstable or life-threatening arrhythmias or cardiac events requiring urgent medical response. Not intended for patients at elevated risk of serious cardiovascular events that would require prompt intervention. It is not intended for monitoring patients during cardiac rehabilitation outside of healthcare facilities. Devices are intended for prescription use only.

510(k) Clearance History

Loading...

Related 510(k) Clearances

This FDA classification is associated with 21 510(k) clearances via K numbers.

K Number Device Name
K250793 RhythmStar System (SL)
K241179 Rhythm Express Remote Cardiac Monitoring System (RX-1 mini)
K240653 SmartCardia 7L Platform (MCT)
K240029 Zio AT® device (A100A1001)
K233584 RhythmStar System
K162956 NOWCARDIO SYSTEM
K170565 LifeWatch Mobile Cardiac Telemetry 3 Lead LifeWatch MCT 3L
K163512 Zio AT ECG Monitoring System
K160064 MoMe Kardia Wireless Ambulatory ECG Monitoring and Detection System
K133753 MOME ECG CONTINUOUS DETECTION AND ARRHYTHMIA DETECTOR
K133701 NUVANT MCT SYSTEM
K113372 NUVANT, MOBILC CARDIAC TELEMETRY
K111917 NUVANT, MOBILE CARDIAC TELEMETRY
K103706 THE CORE (CARDIAC OUTPATIENT REALTIME ECG) MONITOR
K093288 CARDIONET AMBULATORY ECG MONITOR WITH ARRHYTHMIA DETECTION
K090696 NUVANT CARDIAC EVENT MONITORING SYSTEM; NUVANT MOBILE CARDIAC TELEMETRY SYSTEM
K072558 CARDIONET AMBULATORY ECG MONITOR WITH ARRHYTHMIA DETECTION, MODEL CN1005
K063222 CARDIONET AMBULATORY ECG MONITOR WITH ARRHYTHMIA DETECTION, MODEL CN1004
K052240 CARDIONET AMBULATORY ECG MONITOR WITH ARRHYTHMIA DETECTION, MODEL 1002
K020632 ENGUARD REMOTE PATIENT MONITOR
K982803 HEARTLINK, MODEL II

FEI Numbers

This FDA classification entry is associated with 10 FEI numbers. Click on an entry to view related FDA registrations.

Registration Numbers

This FDA classification entry is associated with 10 registration numbers. Click on an entry to view related FDA registrations.